Atopic dermatitis (AD) is frequently associated with eosinophilia, highly elevated immunoglobulin E (IgE) levels and increased levels of T-helper 2-type (Th2) cytokines in skin lesions due to infiltrating T cells. , in combination with interferon-g (IFN-g), inhibits IgE synthesis and Th2 cell function. As the IFN-g-inducing cytokines IL-12 and IL-23 utilize IL-12Rb1 as part of their receptors, it is possible that polymorphic variants of the IL-12Rb1 (IL12RB1) gene might determine an individual's susceptibility to AD. Here, we carried out a systemic search for genetic variants of the human IL12RB1 in Japanese subjects and identified 48 genetic variants. In a case -control association study, we found that promoter polymorphisms 2111A/T and 22C/T were significantly associated with an increased risk of AD under a recessive model. The 2111T-allele frequency in the independent population of child asthmatics was also much higher than that in the control group. In addition, the 2111T/T genotype was progressively more common in AD with high total serum IgE levels in an IgE-level-dependent manner. Deletion analysis of the IL12RB1 promoter suggested that the 2265 to 2104 region that contained the 2111A / T polymorphic site harbored an important regulatory element. Furthermore, we showed that the 2111A/T substitution appeared to cause decreased gene transcriptional activity such that cells from 2111A/A individuals exhibited higher IL12RB1 mRNA levels than those from 2111T allele carriers. Our results suggested that in individuals with the 2111T/T genotype, reduced IL-12Rb1 expression may lead to increased Th2 cytokine production in the skin and contribute to the development of AD and other subsequent allergic diseases.
INTRODUCTION
Atopic dermatitis (AD) is a chronic inflammatory skin disease primarily occurring in infants and children, which is characterized by pruritic and eczematous skin lesions at characteristic locations (1) . Although its prevalence has increased 2 -3-fold during the past three decades in industrialized countries, wide variations in prevalence rates have been observed within countries inhabited by groups with similar genetic backgrounds, suggesting that environmental factors may be critical in determining AD onset (2, 3) . Nonetheless, it is widely accepted that AD has a genetic component responsible for its high familial occurrence. Twin studies of AD have shown concordance rates of 72-86% in monozygotic and 21 -23% in dizygotic twin pairs (4, 5) such that genetic factors also play an important role in AD development. Taken together, it appears that changes in environmental exposure in utero and during the early years of life may lead to the manifestation of AD in genetically predisposed individuals (6) .
AD is frequently associated with blood eosinophilia and highly elevated immunoglobulin E (IgE) levels. Biopsies from clinically unaffected skin from AD patients demonstrate increased number of T-helper 2-type (Th2) cells that express interleukin-4 (IL-4) and IL-13, but not interferon-g (IFN-g), mRNA when compared with normal non-atopic skin (7, 8) . When compared with normal or uninvolved AD skin, acute AD skin lesions exhibit significantly increased number of IL-4, IL-5 and IL-13 mRNA-expressing cells. Furthermore, transgenic mice genetically engineered to over express IL-4 in their skin and to develop inflammatory pruritic skin lesions similar to AD, which suggests that local skin expression of Th2 cytokines plays a critical role in AD (9) .
IL-12, primarily produced by antigen-presenting cells, is a heterodimeric cytokine consists of two disulfide-linked subunits designated as p35 and p40. It plays a central role in regulating Th1 differentiation and in promoting cell-mediated immunity (10) . Conversely, IL-12, in combination with IFN-g, inhibits IgE synthesis and antagonizes Th2 differentiation, including the production of Th2 cytokines such as IL-4 (11) . The IL-12 receptor (IL-12R) consists of at least two distinct subunits, b1 and b2, and is primarily expressed on activated T and NK cells (12) . Co-expression of human IL-12Rb1 and IL-12Rb2 is required for the formation of high-affinity IL-12 binding sites, and analysis of IL-12R-deficient mice showed that both subunits were essential for IL-12R function (13, 14) . Recently, it was reported that IL-12Rb1 is also a component of the receptor complex for another IFN-g-inducing cytokine, IL-23 (15) .
To date, case -control association studies have found significant associations between AD and gene polymorphisms in IL4, IL4R, IL13, RANTES (CCL5), TGFB1, GMCSF (CSF2), CARD15, FCER1B (MS4A2), SPINK5 and IL12B (3,16 -18) . Although few studies have examined the association between Th1-related genes and the development of AD, there have been recent epidemiological studies showing an inverse relationship between AD and Th1-associated phenotypes. For example, AD was inversely associated with insulin-dependent diabetes mellitus, a Th1-biased autoimmune disorder (19) . Moreover, a strong inverse association was also found between positive tuberculin responses and a range of atopic symptoms, including AD (20) . Therefore, we hypothesized that functional single nucleotide polymorphisms (SNPs) in Th1-related genes encoding the IL-12 family of cytokines and cytokine receptors might also contribute to AD susceptibility. To test this hypothesis and to assess the role of IL-12/IL-12R and IL-23/IL-23R systems in AD, we examined the influence of IL-12b1 (IL12RB1) gene polymorphisms in AD susceptibility in the Japanese population.
RESULTS

Identification of sequence variants in IL12RB1
Direct DNA sequencing revealed 48 IL12RB1 variants, which included previously reported variants (21 -24) and 10 novel variants ( -3966C/A, -2163C/T, -1973C/T, -355G/A, 3377C/A, 5854G/A, 9354G/T, 10129G/A, 18205C/T and 20228G/A) in Japanese (Table 1) . We identified nine variants in the 5 0 -flanking region, nine in the coding region (seven nonsynonymous and two synonymous), one in the 5 0 -untranslated region (UTR), one in the 3 0 -UTR, 21 within introns and seven at the 3 0 end. Twelve of the 48 variants had estimated minor allele frequencies (MAFs) of ,10% (on the basis of the sequencing of 24 DNA samples). Nucleotide position one (þ1) was defined as the first adenine of the initiation codon (ATG) and positions for other SNPs were described relative to the ATG on genome contig AC020904. A graphical overview of the structure of the human IL12RB1 gene with the location of the 36 common polymorphisms (MAF ! 10%) identified in this study is shown in Figure 1A .
LD and case -control comparisons
For the successfully genotyped 35 of 36 common variants, we calculated both D 0 and r 2 as statistical values for pair-wise linkage disequilibrium (LD) analysis between SNPs. The LD block structure defined by the 35 genotyped SNPs is shown in Figure 1B . Strong LD was detected across the IL12RB1 region, although at least two historical recombination events seem to have occurred, which divided the region into three strongly correlated LD blocks. Next, on the basis of location and LD with other sites (r 2 , 0.9), we selected eight representative SNPs (-111A/T, -2C/T, 4443C/T, 5970G/C, 17183T/C, 17369C/T, 25748T/C and 27637A/T) from the 36 common polymorphisms for further genotyping and association studies in our AD population. The distribution of all eight SNPs was in Hardy -Weinberg equilibrium in both AD and control groups (P . 0.05).
For the case -control association study, we genotyped the eight selected SNPs in a set of 382 unrelated individuals with AD and 658 population-based controls. The clinical characteristics of our AD patients are summarized in Table 2 . Allele and genotype frequencies of each selected SNP were compared between the patients and the normal controls using the x 2 test under different association models. We found a significant association between two promoter SNPs at 2111 and 22 (2111A/T and -2C/T) and AD in our Japanese cohort under a recessive model (2111AA þ AT versus TT, P ¼ 0.00044; 22CC þ CT versus TT, P ¼ 0.00075; Table 3 ).
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The result for each SNP remained significant after correction for multiple tests (corrected P: P c ¼ 0.0035 for 2111A/T and P c ¼ 0.006 for 22C/T). Homozygotes for the 2111T or 22T alleles were significantly more common in AD patients when compared with controls. Odds ratios (ORs) of developing AD with respect to positions 2111 and 22 were 2.46 (95%CI 1.47 -4.13) and 2.60 (95%CI 1.46-4.61), respectively. Genotype frequencies in Japanese AD cases and controls for 2111 and 22 SNPs were shown in Table 4 .
In further analyses of patient subgroups, we observed strong associations between the presence of high total serum IgE, early age of disease onset ( 3) and peripheral blood eosinophilia (.500/ml), as well as history of childhood asthma and allergic rhinitis (Table 5) . No significant differences were observed for the other clinical features tested (data not shown). Notably, the 2111T/T genotype was progressively more common in AD with high total serum IgE levels in an IgE-level-dependent manner. Interestingly, when we analyzed 
On the basis of the sequencing of 24 DNA samples. Primer sequences are listed in Supplementary Material, Table S1 . the 2111A/T SNP in the independent population of physiciandiagnosed asthma, the 2111T/T genotype frequency in 304 child asthmatics aged 4 -15 years (9.2%) tended to be much higher than that in the control group (4.2%). Then, to further confirm the influence of the 2111 genotype on IgE regulation, we compared total serum IgE levels in AD patients according to genotype. Although the results for AD patients were not statistically significant, we observed the same trend of increasing total serum IgE levels with increasing occurrence of the 2111T allele (Fig. 2 ).
Haplotype analysis
Among eight representative SNPs, SNPs located out of the first LD block were not in strong LD with the 2111 and 22 SNPs (r 2 0.6). We analyzed the distribution of 
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two-locus haplotype in AD, childhood asthma and control samples. Of the two promoter IL12RB1 haplotypes that constituted the 2111A/T and 22C/T SNPs, the 2111A/22C haplotype was the most common, followed by 2111T/22T and 2111T/22C. Association studies for each haplotype with AD identified a borderline-significant association of both the 2111A/22C and 2111T/22T haplotypes with AD (Table 6 ). For child asthmatics, results of the haplotype analysis showed a significant association (global P ¼ 0.005). These associations were not stronger than those observed for the single loci. However, these results cannot exclude the possibility that any other variants lying on the 2111T/22T haplotype may be involved in AD and asthma. We also analyzed the global distribution of IL12RB1 haplotypes comprising the eight SNPs between the patient and control groups. Ten haplotypes, each of which consisted of eight SNPs that had a calculated frequency .1%, were observed in the control group (data not shown). These 10 haplotypes accounted for more than 95% of all haplotypes estimated in the study population.
Expression analysis of IL12RB1 in human tissue panels
Previous reports have shown that IL-12R is detected mostly on activated T cells and NK cells (25) and that dendritic cells express a single class of high-affinity IL-12R (26) . IL-12Rb1 has also been detected on human B cell lines and activated tonsillar B lymphocytes (27) . In this study, to confirm the expression of IL12RB1 mRNA transcripts in target cells, we carried out RT -PCR analysis of multiple tissue cDNA panels. We observed IL12RB1 expression in various tissues including spleen and lymph nodes, as well as in activated mononuclear and CD4 þ cells (Fig. 3) . Furthermore, as shown previously (27) , we also detected transcripts in lymphohematopoietic cell lines (Jurkat, Daudi, MOLT3, MOLT4, THP-1 and U937), but not in HL60, Hela and HEK293 cell lines (data not shown).
Identification of the regulatory elements in the IL12RB1 promoter, transcriptional effect of 2111A/T SNP and association of the 2111 genotype with IL12RB1 mRNA expression
We constructed a deletion panel of the IL12RB1 upstream region encompassing nucleotides 22947 to 265 (Fig. 4A ).
Transcriptional activity of the promoter constructs derived from the wild-type allele (22252G/22060A/22004A/ 2 111A/22C) was analyzed in transiently transfected Jurkat, HEK293 and THP-1 cells by measuring firefly luciferase activity. The relative changes in transcriptional activity among the IL12RB1 promoter constructs were generally similar between the cell lines (data not shown). Deletion of 5 0 sequence between 2762 and 2265 significantly increased activity (1.6-fold in Jurkat cells, P , 0.01), which suggested the presence of a silencer in the 2762/2265 region. Of the promoter constructs tested, the 2265/265 fragment showed the highest activity. Further, 5 0 deletion of this fragment to 2104/265 caused a dramatic reduction of promoter activity to 23% of the 2265/265 fragment (P , 0.001), which suggested that the 2265/2104 region contained an enhancer element.
To determine the effect of the A/T polymorphism at position 2111 on promoter activity, we transiently expressed 2111A and 2111T luciferase reporter constructs (pGL3/ -111A and pGL3/ -111T, respectively) in Jurkat cells. Luciferase activity in cell extracts was analyzed 24 h after transfection and was standardized against internal control Renilla activity. Results indicated that the 2111T construct that consisted of the 2265/265 fragment showed a significant decrease in luciferase reporter activity when compared with the 2111A construct (33%, P , 0.01; Fig. 4B) . Similarly, the 2111T construct had only 40-70% of the 2111A luciferase activity in THP-1 cells and HEK293 cell lines (data not shown), which suggested that the 2111A/T substitution impaired a functional promoter element. Thus, it appeared that the 2111T allele was associated with decreased transcriptional activity of the IL12RB1 gene. We also tested whether the C/T SNP at 22 affected IL12RB1 promoter activity, using the 264/þ64 fragment. Results indicated that the 264/þ64 region that contained the 22C/T SNP had only slight activity in Jurkat cells (Fig. 4A) . Moreover, no significant differences in expression levels were detected between 22C and 22T promoter constructs in transiently transfected Jurkat cells (data not shown). During this study, we had identified three SNPs in the IL12RB1 promoter, which also showed a high degree of LD (22252G/T, 22060A/G and 22004A/G).
Deletion of 5
0 sequence between 22947 and 21668 that contained these SNPs caused no obvious change in transcriptional activity. We also observed almost identical relative luciferase activity between -2252G/ -2060A/ -2004A and 22252T/ -2060G/-2004G promoter constructs (data not shown).
Quantitative real-time PCR was performed to assess IL12RB1 mRNA expression in peripheral blood mononuclear cells (PBMC) from healthy subjects with different 2111 IL12RB1 promoter genotypes (haplotypes). Relative values for IL12RB1 mRNA expression were obtained by dividing the IL12RB1 mRNA abundance by the GAPDH mRNA abundance. Results indicated that the IL12RB1 mRNA expression was significantly higher in anti-CD3-stimulated cells carrying the 2111A/A genotype (2111A/22C homozygotes) when compared with those carrying the 2111T allele (2111A/T or 2111T/T genotypes) (2111AA versus AT þ TT, P ¼ 0.019; -111AA versus AT, P ¼ 0.021; Fig. 4C ). There was a similar tendency observed for unstimulated and PHA-stimulated cells, which was borderline significant (P ¼ 0.04 -0.06). Human
DISCUSSION
In this study, we identified 48 IL12RB1 gene variants, including 10 novel variants, in a Japanese population. We selected eight representative SNPs from 36 common SNPs (MAF ! 10%) for further genotyping and association studies on an AD population. Our results showed that the IL12RB1 promoter SNPs 2111A/T and 22C/T were significantly associated with risk of AD under a recessive model (P , 0.001). Moreover, we observed a positive association between 2111T/T genotype and total serum IgE levels in an IgE-level-dependent manner. The promoter SNPs were shown to be in strong LD with each other (D 0 ¼ 0.99; r 2 ¼ 0.85), and the percentage of 2111T/T and 22T/T genotypes was much higher in AD patients than that in normal controls. Deletion analysis of the IL12RB1 promoter indicated that the 2265 to 2104 region that contained the 2111A/T polymorphic site harbored an important regulatory element. In addition, our data revealed that a single base substitution at the IL12RB1 2111 polymorphic site altered the transcriptional activity of the IL12RB1 gene such that the wild-type IL12RB1 (2111A) reporter construct was transcriptionally more active than the 2111T construct in Jurkat cells. These results suggested that the A/T SNP at position 2111 within the IL12RB1 promoter affects the IL12RB1 gene expression and contributes to increased risk of AD as well as raised total serum IgE levels. This is supported by our data showing the effects of the 2111 genotype on IL12RB1 mRNA levels in stimulated PBMC from healthy volunteers. We also found a trend for an association between total IgE level and IL12RB1 genotype among our Japanese AD patients. Thus, presence of a particular IL12RB1 allele may lower IL12Rb1 expression and allow the development of AD. To the best our knowledge, this is the first report to indicate that the IL12RB1 gene may be involved in AD onset and IgE regulation.
When we analyzed IL12RB1 gene haplotypes, the haplotypic findings of the promoter SNPs were weaker than that of individual SNP associations. These and our functional experiments suggested that these SNPs did not act in combination and that the 22 SNP located within the Kozak consensus sequence had little or no effect on translation efficiency. However, these findings could not exclude the possibility that polymorphisms elsewhere, in LD with the 2111 and 22 SNPs, within or around the IL12RB1 gene might also influence IL12RB1 expression. Our AD patient subgroups analysis also revealed strong associations with the presence of high total serum IgE, early age of disease onset, peripheral blood eosinophilia and history of childhood asthma or allergic rhinitis. Moreover, the percentage of the 2111T/T genotype was much higher in child patients with asthma than that in controls as well as in adult asthmatics. Thus, specific IL12RB1 genotypes may predispose not only toward the development of AD but also toward other atopic conditions such as asthma and allergic rhinitis. In general, the clinical signs of AD predate the development of asthma and allergic rhinitis in the majority of affected patients, giving rise to the so-called 'atopic march', which suggests that AD is an initial step or entry point for subsequent allergic diseases (3, 28) . Therefore, early intervention in AD-susceptible individuals may be an effective strategy in preventing the atopic march. For this reason, IL12RB1 genotype may be an important genetic marker. The lymphocytes infiltrating unaffected skin or acute skin lesions in AD patients tend to be Th2-type T cells that produce IL-4, IL-5 and IL-13, whereas expression of IL-12 and the Th1 cytokine IFN-g are increased in chronic eczematous AD skin lesions (8, 29) . In addition, AD is known to be associated with a high prevalence of skin infections, particularly involving Staphylococcus aureus. Recent studies have shown that at both the mRNA and protein levels, antibacterial peptides such as b-defensins and cathelicidin are decreased or deficient in skin lesions from AD patients when compared with those from psoriasis patients and that the combination of IL-4 and IL-13 inhibited the production of these antimicrobial peptides from keratinocytes (30, 31) . Although the exact mechanisms by which IL-12Rb1 regulates these pathophysiological disease features remain unknown, one possibility is that excess Th2 cytokines block a pathway of innate immune activation, leading to an increased susceptibility to skin infections. This in turn facilitates the continued activation of the adaptive immune system, including the recruitment and activation of atopic Th2 cells and perpetuation of the lesions (32) . Therefore, our findings suggest that IL12RB1 SNPs or haplotypes, which appear to affect protein expression or function, may predispose an individual toward the initiation or development of Th2-mediated immune responses in the skin. Further biological and population studies will be required to confirm the role of IL12RB1 SNPs.
In contrast to AD, the immune response in psoriasis is Th1-mediated and is associated with local neutrophil infiltration. Recent data have indicated that expression of IL-23 and the IL-23-promoting cytokine IL-17 is increased in lesional skin samples of patients with psoriasis vulgaris. As IL-23 utilizes IL-12Rb1 as part of its receptor, it is reasonable to speculate that the same promoter SNPs in IL12RB1 that cause susceptibility to AD might be involved in psoriasis vulgaris as well. Our findings were in accordance with a recent study in Morocco that found an association of pulmonary tuberculosis (TB) with two promoter IL12RB1 SNPs at 2111 and 22 (24) . Moreover, an association between heterozygous mutations of the IL12RB2 gene and reduced IFN-g production by PBMC following stimulation by IL-12 in some Japanese atopic subjects has also been reported (33) and IL12B has been identified as a susceptibility gene in patients with AD (18), asthma (34) and type 1 diabetes (35) . These studies along with our present data suggest that functionally relevant SNPs in the IL-12/IL-12R and IL-23/IL-23R systems may be associated with the genetic susceptibility to a variety of diseases, including AD and TB. The human IL12RB1 gene is located on chromosome 19p13.1. Although this region has not been previously implicated by AD linkage studies, a recent study suggested that chromosome 19p13 might harbor a genetic determinant of IgE-related traits (36) . Another report showed modest evidence of linkage for atopic phenotypes on chromosome 19p13.3 in an Italian population (37) , and a genome-wide scan of a large cohort of German families revealed significant evidence for a psoriasis-susceptibility locus on 19p13 (38) . Thus, chromosome 19p13 may indeed contain immunoregulatory genes that influence inflammatory skin diseases such as AD and/or atopy-related phenotypes. In addition, the IL12RB1 gene is a novel and attractive candidate susceptibility gene for skin inflammatory diseases such as AD, on the basis of its location as well as its function. However, further genetic analyses and biological studies will be required to address whether other atopic disease-related genes or SNPs are also present on 19p13.
In conclusion, we have identified 48 variants (10 novel) of the human IL12RB1 gene. Our studies demonstrated that the -111T/T IL12RB1 genotype was associated with high total serum IgE levels and AD susceptibility in a Japanese population. Furthermore, we showed that the -111A/T polymorphism affected the IL12RB1 gene transcriptional activity and may contribute to low IL-12Rb1 expression levels. In individuals with the -111T/T genotype, reduced IL-12Rb1 expression may lead to increased Th2 cytokine production in the skin and contribute to the development of AD and other subsequent allergic diseases. Our findings also highlighted the importance of the IL-12 -IFN-g and/or IL-23 -IL-17 pathway in the pathogenesis of AD and regulation of IgE. Although the exact functional role of IL-12Rb1 in AD remains to be elucidated, the identification of SNPs in IL12RB1 as a risk factor for AD may provide a strategy to prevent disease onset in susceptible individuals and to represent an attractive target for future therapies for this disorder.
MATERIALS AND METHODS
Study subjects
A total of 382 AD patients (mean age 30.2 years, range 16 -65 years; 193 females and 189 males; mean total serum IgE level 2815 IU/ml) were recruited from Yokohama City University Hospital and Kyoto Takao Hospital. All patients with AD were diagnosed by dermatologists according to the criteria of Hanifin and Rajka (39) . Controls for the SNP association study were 658 unrelated healthy individuals with an age range of 18 -83 years, were from the same geographical areas as the AD patients and had no symptoms or personal and family histories of AD, asthma or allergic rhinitis. We also recruited 304 patients with childhood asthma with an age range of 4-15 years, who have been included in a previous study (40) . All subjects in this study were ethnically 
Screening for polymorphisms and genotyping
To identify genetic variants of the human IL12RB1 gene, we sequenced all 17 exons, adjacent intronic sequence, 4.0 kb 5 0 flanking region and 1.5 kb 3 0 -flanking region in 24 individuals from our study cohort. On the basis of IL12RB1 genomic and mRNA sequences from the GenBank database (accession nos AC020904 and U03187, respectively), 25 primer sets were designed (Supplementary Material). All PCR products were sequenced using BigDye terminator v3.1 and an ABI Prism 3700 Genetic Analyzer (PE Applied Biosystems, Foster City, CA, USA). The sequences were analyzed and polymorphisms identified using the SEQUENCHER program (Gene Codes Corporation, Ann Arbor, MI, USA). On the basis of information available from the public JSNP database (http://snp.ims.u-tokyo.ac.jp), eight selected SNPs were genotyped by one of two methods: the Invader assay (41) (for -111A/T:IMS-JST063138, -2C/T:IMS-JST063137, 4443C/ T:IMS-JST063136, 17183T/C:IMS-JST063134 and 27637T/ A:IMS-JST097711) and the TaqMan assay (for 5970G/C, 17369C/T and 25748T/C) on an ABI PRISM 7700 Sequence 0 , with 5 0 -CCGTCCCCACTCCGGAACAC-3 0 used as a common reverse primer. Using plasmid DNA as template, 2111T constructs were created using the QuickChange Site-Directed Mutagenesis kit (Stratagene, USA), forward primer (5 0 -CTTTTTTCTTTTTTTTCTGTCTTTTCTCCTTG CTCAGCTTC-3 0 ), complementary reverse primer and the various pGL3-basic clones. The orientation and integrity of the inserts for each construct were confirmed by DNA sequencing. Jurkat cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum at 378C in an atmosphere of 5% CO 2 . Subconfluent cells cultured in 12-well plates were transiently cotransfected with 2 mg pG L3-basic vector DNA or each reporter construct and 40 ng pRL-TK vector DNA (Promega) as an internal control for transfection efficiency, using DMRIE-C transfection reagent (Invitrogen, San Diego, CA, USA) according to the manufacture's instructions. After 24 h, cells were harvested, and firefly and Renilla luciferase activities measured as previously described (40) . Data are presented as relative luciferase activity of firefly/Renilla luciferase activity.
PBMC preparation
To analyze IL12RB1 mRNA expression, PBMCs from 16 randomly selected healthy individuals were isolated by Ficoll density gradient centrifugation, after which 1 Â 10 6 cells/ml PBMC were cultured in RPMI-1640 supplemented with 10% fetal bovine serum, 1% HEPES buffer, 1% L-glutamine, 1% sodium pyruvate, 1% non-essential amino acids and 1% penicillin -streptomycin solution. PBMCs were stimulated with 100 mg/ml PHA or 100 mg/ml anti-CD3 antibody for 72 h at 378C in a 5% CO 2 atmosphere.
Real-time quantitative PCR
Total RNA was isolated from cultured PBMC using the NucleoSpin 96 RNA kit (MACHEREY-NAGEL, Düren, Germany), according to the manufacturer's instructions. cDNA was then synthesized using the SuperScript III FirstStrand Synthesis System (Invitrogen). Real-time quantitative PCR was performed on the ABI PRISM 7900 (Applied Biosystems) using an Assay-on-Demand TaqMan probe and primers (Hs00234651_ml for IL12RB1 ), according to the manufacturer's instructions. Relative expression levels of IL12RB1 mRNA were normalized according to GAPDH expression, using a standard curve method as described by the manufacturer.
Statistical analysis
We calculated allele frequencies and tested agreement with Hardy -Weinberg equilibrium using a x 2 goodness-of-fit test at each locus. We also compared differences in allele frequencies and genotype distribution of each polymorphism between case and control subjects, using a 2 Â 2 contingency x 2 test with one degree of freedom or Fisher's exact test. All P-values are unadjusted for multiple comparisons unless specifically indicated. We calculated LD coefficients (D 0 and r 2 ) using the SNP Alyze statistical package (Dynacom, Chiba, Japan), as described elsewhere (42) . We estimated haplotype frequencies using the expectation-maximization algorithm. We calculated ODs with 95% confidence intervals (95%CI) using logistic regression. Comparisons in reporter assays as well as quantitative PCR experiments were performed using Student's t-test. Association between logtransformed total serum IgE levels in AD patients and individual genotypes was calculated by the Mann -Whitney U-test or the Kruskal -Wallis test. A P-value of less than 0.05 was considered to indicate statistical significance.
